IL-15 enables septic shock by maintaining NK cell integrity and function

Journal of Immunology

Volumn 198, Issue 3, 2017, Pages 1320-1333

  Guo, Yin ^a   Luan, Liming ^a   Patil, Naeem K ^a   Wang, Jingbin ^a   Bohannon, Julia K ^a   Rabacal, Whitney ^a   Fensterheim, Benjamin A ^a   Hernandez, Antonio ^a   Sherwood, Edward R ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DISEASE SEVERITY; EXPERIMENTAL LIGATION; FEMALE; GENE SILENCING; HYPOTHERMIA; MALE; MORTALITY; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; PROTEIN DEPLETION; SEPTIC SHOCK; SURVIVAL RATE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; IMMUNOLOGY; KNOCKOUT MOUSE; MOUSE; PHYSIOLOGY; SHOCK, SEPTIC;

ANIMALS; FEMALE; INTERFERON-GAMMA; INTERLEUKIN-15; KILLER CELLS, NATURAL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SHOCK, SEPTIC;

EID: 85014707915     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1601486     Document Type: Article

References (44)

1. Puzanov, I. J., M. Bennett, and V. Kumar. 1996. IL-15 can substitute for the marrow microenvironment in the differentiation of natural killer cells. J. Immunol. 157: 4282-4285.
2. Huntington, N. D., N. Legrand, N. L. Alves, B. Jaron, K. Weijer, A. Plet, E. Corcuff, E. Mortier, Y. Jacques, H. Spits, and J. P. Di Santo. 2009. IL-15 transpresentation promotes human NK cell development and differentiation in vivo. J. Exp. Med. 206: 25-34.
3. Mortier, E., T. Woo, R. Advincula, S. Gozalo, and A. Ma. 2008. IL-15Ralpha chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation. J. Exp. Med. 205: 1213-1225.
4. Zhang, X., S. Sun, I. Hwang, D. F. Tough, and J. Sprent. 1998. Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity 8: 591-599.
5. Schluns, K. S., K. Williams, A. Ma, X. X. Zheng, and L. Lefrançois. 2002. Cutting edge: requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells. J. Immunol. 168: 4827-4831.
6. Malamut, G., R. El Machhour, N. Montcuquet, S. Martin-Lannerée, I. Dusanter-Fourt, V. Verkarre, J. J. Mention, G. Rahmi, H. Kiyono, E. A. Butz, et al. 2010. IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesis. J. Clin. Invest. 120: 2131-2143.
7. Lodolce, J. P., D. L. Boone, S. Chai, R. E. Swain, T. Dassopoulos, S. Trettin, and A. Ma. 1998. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 9: 669-676.
8. Kennedy, M. K., M. Glaccum, S. N. Brown, E. A. Butz, J. L. Viney, M. Embers, N. Matsuki, K. Charrier, L. Sedger, C. R. Willis, et al. 2000. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 191: 771-780.
9. Fehniger, T. A., and M. A. Caligiuri. 2001. Interleukin 15: biology and relevance to human disease. Blood 97: 14-32.
10. Ma, A., R. Koka, and P. Burkett. 2006. Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu. Rev. Immunol. 24: 657-679.
11. Mattei, F., G. Schiavoni, F. Belardelli, and D. F. Tough. 2001. IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation. J. Immunol. 167: 1179-1187.
12. Ahmad, R., J. Ennaciri, P. Cordeiro, S. El Bassam, and J. Menezes. 2007. Herpes simplex virus-1 up-regulates IL-15 gene expression in monocytic cells through the activation of protein tyrosine kinase and PKC zeta/lambda signaling pathways. J. Mol. Biol. 367: 25-35.
13. Blaser, B. W., N. R. Schwind, S. Karol, D. Chang, S. Shin, S. Roychowdhury, B. Becknell, A. K. Ferketich, D. F. Kusewitt, B. R. Blazar, and M. A. Caligiuri. 2006. Trans-presentation of donor-derived interleukin 15 is necessary for the rapid onset of acute graft-versus-host disease but not for graft-versus-tumor activity. Blood 108: 2463-2469.
14. Castillo, E. F., S. W. Stonier, L. Frasca, and K. S. Schluns. 2009. Dendritic cells support the in vivo development and maintenance of NK cells via IL-15 transpresentation. J. Immunol. 183: 4948-4956.
15. Han, K. P., X. Zhu, B. Liu, E. Jeng, L. Kong, J. L. Yovandich, V. V. Vyas, W. D. Marcus, P. A. Chavaillaz, C. A. Romero, et al. 2011. IL-15:IL-15 receptor alpha superagonist complex: high-level co-expression in recombinant mammalian cells, purification and characterization. Cytokine 56: 804-810.
16. Rubinstein, M. P., M. Kovar, J. F. Purton, J. H. Cho, O. Boyman, C. D. Surh, and J. Sprent. 2006. Converting IL-15 to a superagonist by binding to soluble IL-15Ralpha. Proc. Natl. Acad. Sci. USA 103: 9166-9171.
17. Sherwood, E. R., V. T. Enoh, E. D. Murphey, and C. Y. Lin. 2004. Mice depleted of CD8+ T and NK cells are resistant to injury caused by cecal ligation and puncture. Lab. Invest. 84: 1655-1665.
18. Enoh, V. T., C. D. Fairchild, C. Y. Lin, T. K. Varma, and E. R. Sherwood. 2006. Differential effect of imipenem treatment on wild-type and NK cell-deficient CD8 knockout mice during acute intra-abdominal injury. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290: R685-R693.
19. Tao, W., V. T. Enoh, C. Y. Lin, W. E. Johnston, P. Li, and E. R. Sherwood. 2005. Cardiovascular dysfunction caused by cecal ligation and puncture is attenuated in CD8 knockout mice treated with anti-asialoGM1. Am. J. Physiol. Regul. Integr. Comp. Physiol. 289: R478-R485.
20. Orinska, Z., M. Maurer, F. Mirghomizadeh, E. Bulanova, M. Metz, N. Nashkevich, F. Schiemann, J. Schulmistrat, V. Budagian, J. Giron-Michel, et al. 2007. IL-15 constrains mast cell-dependent antibacterial defenses by suppressing chymase activities. Nat. Med. 13: 927-934.
21. Chung, K. P., H. T. Chang, S. C. Lo, L. Y. Chang, S. Y. Lin, A. Cheng, Y. T. Huang, C. C. Chen, M. R. Lee, Y. J. Chen, et al. 2015. Severe lymphopenia is associated with elevated plasma interleukin-15 levels and increased mortality during severe sepsis. Shock 43: 569-575.
22. Kimura, A., S. Ono, S. Hiraki, R. Takahata, H. Tsujimoto, H. Miyazaki, M. Kinoshita, K. Hatsuse, D. Saitoh, K. Hase, and J. Yamamoto. 2012. The postoperative serum interleukin-15 concentration correlates with organ dysfunction and the prognosis of septic patients following emergency gastrointestinal surgery. J. Surg. Res. 175: e83-e88.
23. Herzig, D. S., L. Luan, J. K. Bohannon, T. E. Toliver-Kinsky, Y. Guo, and E. R. Sherwood. 2014. The role of CXCL10 in the pathogenesis of experimental septic shock. Crit. Care 18: R113.
24. Lebrec, H., M. J. Horner, K. S. Gorski, W. Tsuji, D. Xia, W. J. Pan, G. Means, G. Pietz, N. Li, M. Retter, et al. 2013. Homeostasis of human NK cells is not IL-15 dependent. J. Immunol. 191: 5551-5558.
25. Cooper, M. A., J. E. Bush, T. A. Fehniger, J. B. VanDeusen, R. E. Waite, Y. Liu, H. L. Aguila, and M. A. Caligiuri. 2002. In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells. Blood 100: 3633-3638.
26. Chiossone, L., J. Chaix, N. Fuseri, C. Roth, E. Vivier, and T. Walzer. 2009. Maturation of mouse NK cells is a 4-stage developmental program. Blood 113: 5488-5496.
27. Guo, Y., L. Luan, W. Rabacal, J. K. Bohannon, B. A. Fensterheim, A. Hernandez, and E. R. Sherwood. 2015. IL-15 Superagonist-Mediated Immunotoxicity: Role of NK Cells and IFN-γ. J. Immunol. 195: 2353-2364.
28. Emoto, M., M. Miyamoto, I. Yoshizawa, Y. Emoto, U. E. Schaible, E. Kita, and S. H. Kaufmann. 2002. Critical role of NK cells rather than V alpha 14(+) NKT cells in lipopolysaccharide-induced lethal shock in mice. J. Immunol. 169: 1426-1432.
29. Christaki, E., E. Diza, E. J. Giamarellos-Bourboulis, N. Papadopoulou, A. Pistiki, D. I. Droggiti, M. Georgitsi, A. Machova, D. Lambrelli, N. Malisiovas, et al. 2015. NK and NKT cell depletion alters the outcome of experimental pneumococcal pneumonia: relationship with regulation of interferon-γ production. J. Immunol. Res. 2015: 532717.
30. Badgwell, B., R. Parihar, C. Magro, J. Dierksheide, T. Russo, and W. E. Carson, III. 2002. Natural killer cells contribute to the lethality of a murine model of Escherichia coli infection. Surgery 132: 205-212.
31. Goldmann, O., G. S. Chhatwal, and E. Medina. 2005. Contribution of natural killer cells to the pathogenesis of septic shock induced by Streptococcus pyogenes in mice. J. Infect. Dis. 191: 1280-1286.
32. Barkhausen, T., C. Frerker, C. Pütz, H. C. Pape, C. Krettek, and M. van Griensven. 2008. Depletion of NK cells in a murine polytrauma model is associated with improved outcome and a modulation of the inflammatory response. Shock 30: 401-410.
33. Herzig, D. S., B. R. Driver, G. Fang, T. E. Toliver-Kinsky, E. N. Shute, and E. R. Sherwood. 2012. Regulation of lymphocyte trafficking by CXC chemokine receptor 3 during septic shock. Am. J. Respir. Crit. Care Med. 185: 291-300.
34. Bohannon, J., Y. Guo, and E. R. Sherwood. 2012. The role of natural killer cells in the pathogenesis of sepsis: the ongoing enigma. Crit. Care 16: 185.
35. Herzig, D., G. Fang, T. E. Toliver-Kinsky, Y. Guo, J. Bohannon, and E. R. Sherwood. 2012. STAT1-deficient mice are resistant to cecal ligation and puncture-induced septic shock. Shock 38: 395-402.
36. Morvan, M. G., and L. L. Lanier. 2016. NK cells and cancer: you can teach innate cells new tricks. Nat. Rev. Cancer 16: 7-19.
37. Jost, S., and M. Altfeld. 2013. Control of human viral infections by natural killer cells. Annu. Rev. Immunol. 31: 163-194.
38. Etogo, A. O., J. Nunez, C. Y. Lin, T. E. Toliver-Kinsky, and E. R. Sherwood. 2008. NK but not CD1-restricted NKT cells facilitate systemic inflammation during polymicrobial intra-abdominal sepsis. J. Immunol. 180: 6334-6345.
39. Herzig, D. S., Y. Guo, G. Fang, T. E. Toliver-Kinsky, and E. R. Sherwood. 2012. Therapeutic efficacy of CXCR3 blockade in an experimental model of severe sepsis. Crit. Care 16: R168.
40. Sherwood, E. R., C. Y. Lin, W. Tao, C. A. Hartmann, J. E. Dujon, A. J. French, and T. K. Varma. 2003. Beta 2 microglobulin knockout mice are resistant to lethal intraabdominal sepsis. Am. J. Respir. Crit. Care Med. 167: 1641-1649.
41. Hu, C. K., F. Venet, D. S. Heffernan, Y. L. Wang, B. Horner, X. Huang, C. S. Chung, S. H. Gregory, and A. Ayala. 2009. The role of hepatic invariant NKT cells in systemic/local inflammation and mortality during polymicrobial septic shock. J. Immunol. 182: 2467-2475.
42. Patil, N. K., L. Luan, J. K. Bohannon, Y. Guo, A. Hernandez, B. Fensterheim, and E. R. Sherwood. 2016. IL-15 superagonist expands mCD8+ T, NK and NKT cells after burn injury but fails to improve outcome during burn wound infection. PLoS One 11: e0148452.
43. Inoue, S., J. Unsinger, C. G. Davis, J. T. Muenzer, T. A. Ferguson, K. Chang, D. F. Osborne, A. T. Clark, C. M. Coopersmith, J. E. McDunn, and R. S. Hotchkiss. 2010. IL-15 prevents apoptosis, reverses innate and adaptive immune dysfunction, and improves survival in sepsis. J. Immunol. 184: 1401-1409.
44. Fink, M. P. 2014. Animal models of sepsis. Virulence 5: 143-153.